Uzbekistan says 18 deaths linked to Indian-made syrup, pharmaceutical company responds

Cough syrup deaths in Uzbekistan: India has launched an investigation into the claims.

New Delhi:

Uzbekistan has announced that at least 18 children in the country have died after allegedly drinking an Indian-made cough syrup.

The Uzbek Health Ministry, in a statement, said the children who died had been drinking Doc-1 Max cough syrup, made by Noida-based Marion Biotech.

India has opened an investigation into the matter and production of cough syrup has been halted at the pharmaceutical company’s Noida unit until samples are tested.

According to the Uzbek Health Ministry, laboratory tests on one batch of syrup found “the presence of ethylene glycol,” a toxic substance.

It also said the syrup was given to children at home without a doctor’s prescription, by their parents or on the advice of a pharmacist, in doses exceeding the standard dosage for children.

It was found that pre-hospitalized children took this syrup at home for 2-7 days, in doses ranging from 2.5 to 5 ml, three to four times a day, exceeding the dosage. standards, the ministry said.

The syrup is used by parents as a remedy against colds.

Following the deaths of 18 children, Doc-1 Max tablets and syrup were withdrawn from all pharmacies in the country, the statement said, adding that seven employees were fired because they failed to analyze the situation. timely figure and take steps.

A joint investigation is being carried out by the teams of the Central Drug Standards Control Organization (CDSCO – northern region) and the Uttar Pradesh Drug Control and Licensing Authority.

A casualty assessment report has also been requested from Uzbekistan.

Marion Biotech said that cough syrup samples have been collected from their manufacturing unit and are currently awaiting test reports.

“The government is conducting an investigation. We will act on their report, for now, production has stopped,” said Hasan Raza, legal head of Marion Biotech Pharma.

This is the second time in five Indian-made cough syrups that have been screened.

This early year, the deaths of 70 children in the Gambia is linked to cough syrup made by Haryana-based Maiden Pharmaceuticals.

In October, the Central Drug Standards Control Organization closed its unit in Sonepat for violating manufacturing standards.

WHO previously said that laboratory analysis of Maiden cough syrup confirmed “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney damage.

In response to WHO, Drugs Control-General, VG Somani, said that tests on samples of Maiden’s products at government laboratories were “found to comply with specifications” and failed to detect any harmful substances found in it.


News5s: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button